Shots: The approval is based on three P-III studies (NCT02656069, NCT03091673, NCT03439072) assessing GVOKE vs conventional glucagon emergency kits in adults and children aged ≥2yrs. with T1D The studies demonstrated […]readmore
Tags : glucagon
Shots: The FDA’s approval follows multiple studies with various age group evaluating baqsimi (glucagon, 3mg) nasal powder vs glucagon injection formulation in patients with diabetes aged 4yrs and older Collective […]readmore